https://orcid.org/0000-0001-9571-1646
References
- Lyman GH, Dale DC, Culakova E, et al. The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2013;24(10):2475–2484.
- D'Souza A, Jaiyesimi I, Trainor L, et al. Granulocyte colony-stimulating factor administration: adverse events. Transfus Med Rev. 2008;22(4):280–290.
- Sugai Y, Toyoguchi Y, Kanoto M, et al. Clinical and image features: large-vessel vasculitis after granulocyte colony stimulating factor administration. Acta Radiol. 2020. DOI:10.1177/0284185120931685.
- Watanabe T, Mizowaki T, Arakawa Y, et al. Pineal parenchymal tumor of intermediate differentiation: treatment outcomes of five cases. Mol Clin Oncol. 2014;2(2):197–202.
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.
- Oshima Y, Takahashi S, Tani K, et al. Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database. Cytokine. 2019;119:47–51.
- Taimen K, Heino S, Kohonen I, et al. Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review. Rheumatol Adv Pract. 2020;4(1):rkaa004.
- Miller EB, Grosu R, Landau Z. Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol. 2016;35(6):1655–1657.
- Nakamura J, Nishi TM, Yamashita S, et al. Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: a case report and review of the literature. J Oncol Pharm Pract. 2020;26(7):1785–1790.
- Sato Y, Kaji S, Ueda H, et al. Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardiothorac Surg. 2017;52(5):993–994.
- Parodis I, Dani L, Notarnicola A, et al. G-CSF-induced aortitis: two cases and review of the literature. Autoimmun Rev. 2019;18(6):615–620.